Giovanni Biricolti

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Eli Lilly (Italy)(Current)

Eli Lilly (United States)

Giovanni Biricolti is an author at Eli Lilly (Italy) specializing in diabetes medication use, glucagon-like peptide-1 receptor agonists, and diabetes mellitus.

Publications per year

2018–2019

Publications

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study

Marco Orsini Federici, Janette P. McQuillan, Giovanni Biricolti et al. · Diabetes Therapy · 2018 · 37 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy

Kristina S. Boye, Louis S. Matza, Katie D. Stewart et al. · Journal of Medical Economics · 2019 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

Louis S. Matza, Kristina S. Boye, Jessica Jordan et al. · Patient Preference and Adherence · 2018 · 17 citations · Full text

Medicine, Internal Medicine, Clinical Pharmacology +16

1–3 of 3